Collecting real world evidence to achieve product authorisation, accelerate market access, and drive product adoption
With ICON you have access to dedicated outcomes research experts, with deep knowledge and insight to design your study to meet your specific objectives. We design your study with input from leading epidemiologists, medical and scientific affairs experts, COA authors, KOLs and access to Mapi Research Trust.
40years of late phase experience
600+dedicated operational experts
40+expertise in over 40 countries
ICON is the industry’s most experienced real patient research organisation, with over 40 years of experience, and 600+ dedicated peri- and post-approval operational experts in 40+ countries.
We understand the unique challenges of late phase research, and deliver an integrated approach to drive your success.
We design and implement your study with specific milestone and budget guarantees, supported by fully engaged senior leadership governance, and full team, timeline and budget transparency.
Integrated Patient and Site Engagement
Through our collaboration with leading EHR providers, we help identify real patients and the most appropriate research sites. Our dedicated patient engagement and direct to patient contact teams ensure that your patients, sites and investigators are fully engaged throughout the study.
Global Research Services Hubs
Our dedicated global research hubs provide 24/7 support for your studies.Staffed by late phase experts, who are fluent in over 35 languages, they deliver unparalleled global support for interventional trials, pragmatic research, real world research and patient support programs.
Whitepaper: Rare & Orphan Diseases Reimbursement Strategies Roundtable - Part I: Identifying Evidence
Download our whitepaper to read our experts' perspectives on various challenges in identifying the proper evidence necessary to support reimbursement across geographies globally, including the role of patient-reported outcomes (PROs) and patient advocacy organisations.